Stay updated on Combining DC Vaccine and Nivolumab in Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Combining DC Vaccine and Nivolumab in Lung Cancer Clinical Trial page.

Latest updates to the Combining DC Vaccine and Nivolumab in Lung Cancer Clinical Trial page
- CheckyesterdayChange DetectedThe page’s footer/app revision label was updated from v3.5.2 to v3.5.3, indicating a site/version change rather than any modification to the nct04199559 study record.SummaryDifference0.1%

- Check8 days agoChange DetectedAdded Revision: v3.5.2; Deleted Revision: v3.5.0.SummaryDifference0.1%

- Check15 days agoNo Change Detected
- Check37 days agoChange DetectedAdded Revision: v3.5.0 and deleted Revision: v3.4.3 in the Record History.SummaryDifference0.1%

- Check44 days agoChange DetectedRecord history shows a new Revision: v3.4.3 and removal of Revision: v3.4.2.SummaryDifference0.1%

- Check73 days agoChange DetectedAdded revision v3.4.2 to the record history and removed the older v3.4.1 funding/operating-status notices.SummaryDifference0.9%

- Check80 days agoChange DetectedAdded a site-wide funding notice and updated the page revision from v3.4.0 to v3.4.1.SummaryDifference0.9%

Stay in the know with updates to Combining DC Vaccine and Nivolumab in Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Combining DC Vaccine and Nivolumab in Lung Cancer Clinical Trial page.